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In a cohort study, subjects are followed-up over a long period. In addition to baseline 
characteristics, often longitudinal measurements thought to be important predictors of survival are 
collected at discrete time points for all or a subset of cohort members. Joint modeling of survival and 
longitudinal data is commonly used to overcome the issue that the actual longitudinal measurement at 
the time of event is often unknown due to the discrete nature of the measurements. There have been 
few studies that investigated the use of joint modeling under the nested case-control (NCC) sampling, 
despite the great potential of cost savings offered by the design. In this thesis, we compared the 
performance of a published maximum likelihood estimation (MLE) method to a weighted MLE method 
that we proposed. We applied both methods to a simulation study and a real data application and found 
that the estimated values for both weighted and published method are almost similar, but our proposed 
method can be used when only information on those selected into the NCC study is available. 
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Chapter 1 Introduction 
1.1 Motivations behind joint modeling 
 In the research on the causes and effects of diseases, epidemiologists can choose either a cohort 
study or a case-control study design. Particularly in cohort studies, subjects are followed-up over a 
number of years where repeated measurements for each subject can be taken, accumulating in a large 
amount of longitudinal data which can be important predictors of an outcome of interest. These 
longitudinal data records changes over time at the individual level and is essential in the study of chronic 
diseases as most of these diseases may result from a cumulative process that extended over a 
substantial period of time[1].   
In our study, we focused on survival, or more accurately, death or the diagnosis of disease as the 
outcome of interest. In a cohort study, a subject may leave the study at any time due to death or other 
factors such as migration and so the time-to-event or time-to-censor is measured continuously. On the 
other hand, the repeated measurements of the subjects are only taken at fixed, discrete time points 
when the follow-up examinations are being conducted.  The actual value of the covariates of interest 
immediately before the event occurs is unknown and could potentially be the most important predictor 
of the event. A simple and direct method of analysis is to use the measurement of the covariates taken 
at the time closest to the time of event as a means of linear extrapolation. However, if the trajectory of 
the data is not linear, it may present another set of problems, namely the closest measurement may not 
be close to the realized amount of exposure experienced immediately before the event. In order to 
overcome this issue, we have to perform a trajectory analysis on the longitudinal data. 
A trajectory analysis is needed primarily to model the longitudinal outcome, allowing us to 
estimate the covariate at the specific event time, and the evolution of the longitudinal profile itself. 
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Furthermore, certain factors may influence the trajectory of the longitudinal data, and we could include 
these as covariates in the trajectory function, which is important when targeting specific group of 
people in the population.  
So, how do we incorporate the trajectory function in a survival analysis with longitudinal data? 
To address this question, we jointly model the trajectory of the longitudinal data and the time-to-event 
data. To put it in simpler terms, the trajectory function can be included into the survival model of the 
time-to-event data as a time-dependent covariate. The parameters of the joint model can then be 
estimated using the usual inference procedures and the effect of the longitudinal covariate can then be 
quantified through the regression parameter that characterizes the dependence between survival and 
the trajectory function.  This methodology of joint modeling will be explored in details in Chapter 2. 
 
1.2 Joint modeling in the literature 
 There have been many studies done on the joint model of longitudinal and survival data. 
In a  a very comprehensive review published in 2004 [2], more than 20 such studies were discussed. 
More recently, Wu et al. [3]also provided a brief overview of the commonly used methods of joint 
modeling and included some recent developments in this research area that were not discussed in the 
2004 paper. Most of the papers featured in this literature review were also reviewed in the two articles 
above and will cover different methods of parameter estimation in the joint modeling of longitudinal 
and survival data. 
One of the earliest and most common approaches in joint modeling is the computationally 
simpler two-stage approach. Wu et al. [3] described the naïve two-stage method as the fitting of a linear 
mixed-effects model to the longitudinal data for the estimation of the true unobserved values in the first 
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stage and then fitting the survival model separately using these estimates by treating them as observed 
values in the second stage. A variation of this approach was used in the study on longitudinal CD4 counts 
and survival in patients with acquired immune deficiency syndrome (AIDS) by Tsiatis, DeGruttola and 
Wulfsohn [4]. Their aim was to examine whether CD4 counts may serve as suitable surrogates for 
survivals among patients with AIDS. They were concerned that the high variability of the periodic 
longitudinal measurements could be due to measurement error or true biological differences.  If there is 
indeed measurement error, coupled with the problem of missing data, the estimation of the association 
between hazard and the true value of the longitudinal covariate will be biased. 
 Tsiatis et al. developed a two-stage approach to study the association between the hazard rate 
of dying and assembled history of CD4 count. In the first stage, the longitudinal measurements were 
modeled using a linear mixed effects model described by Laird and Ware[5]. In the second stage, the 
Cox model was used to approximate the relationship between hazard and some function of CD4 counts 
up to a time t as summarized by the random components. They then used the empirical Bayes estimates 
of the individual random effects in the first stage to substitute the random components in the partial 
likelihood in the second stage for maximization. By replacing the random components of the covariates 
with the empirical Bayes estimates, the bias of the regression parameter estimate is reduced. 
 This two-stage approach proposed by Tsiatis et al. may be implemented using standard software, 
which is an advantage over many more computationally-intensive methods. The two other papers 
selected for this review have also studied this approach of inference, i.e. the papers by Bycott and Taylor 
(1998)[6] and Dafni and Tsiatis (1998)[7]. The former investigated the performance of the estimates 
inferred using the two-stage approach where different smoothing techniques were employed in the first 
stage of the approach. The latter studied and compared the two-stage approach to a naïve approach 
where the longitudinal profile of the covariate was not modeled and the observed value of the covariate 
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was used in the Cox model. Both papers concluded that the two-stage approach does produce 
regression parameters that are less biased but this bias is not completely eliminated due to two reasons. 
First, the approximation itself and second, the departure from normality due to the selection bias of 
subjects in the risk set at any event time, which is dependent on their survival, for the fitting of the 
mixed model. 
 Wu et al. [3] elaborated more regarding the reason for the bias of the two-stage approach. 
Firstly, the first stage model fitting involved only observed covariate data and hence, the estimated 
parameters may be biased. The magnitude of this bias is dependent on the strength of association 
between the longitudinal and survival process. Secondly, by treating the estimated values as observed 
values in the second stage, the uncertainty of the estimation is not taken into account. Therefore, the 
magnitude of the measurement error in the covariates will influence the bias introduced in this stage 
and the standard errors in the survival model will also be underestimated. Lastly, the efficiency is also 
compromised because the model fitting is performed separately and information in both survival and 
longitudinal processes is not fully combined. 
Tsiatis then proceeded on to develop a likelihood approach for the joint modeling problem with 
a co-author Wulfsohn in 1997[8]. In this paper, they critiqued the two-stage modeling approach which 
they argued is limited by four weaknesses. The first is that the normality assumption of the random 
effects in the risk set at each event time may not be reasonable due to the same reason given by the 
two papers earlier. Also, the two-stage model does not fully utilize the survival information in modeling 
the covariate process which was also mentioned by Wu et al. They also critiqued the use of the 
polynomial growth curve models to simplify the partial likelihood; one weakness of this simplification is 
that a first-order approximation is required, and the other weakness is the fitting of new growth curves 
to each individual at each new event makes the model  difficult to interpret and less parsimonious. 
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 Using the same dataset in the original 1995 paper, Wulfsohn and Tsiatis started a study with the 
aim of investigating the CD4 trajectories and to evaluate the strength of its relationship to survival. 
Again, the CD4 trajectories was assumed to follow a linear mixed model and the parameter estimates 
were obtained by maximizing the joint likelihood of the longitudinal and survival process using an 
expectation-maximization (EM) algorithm. The advantage of this methodology over the two-stage 
approach is in its enhanced efficiency by simultaneously utilizing data from both the covariate and 
survival process. They also assumed constant random effects over time which are normally distributed 
and thus are identical at all event times while the individual is among the risk set unlike the assumption 
of the two-stage approach. Most importantly, their findings from this study showed that the bias is 
further reduced than the two-stage model. One other strength of this likelihood approach is that it could 
be generalized to other modeling situations. However, they acknowledged that the EM algorithm used 
for parameter estimation is slow though reliable. At the time of publication, the authors were also 
exploring the feasibility of using a Newton-Raphson approach instead of the EM algorithm. 
 The normality assumption imposed on the methodology presented by Wulfsohn and Tsiatis have 
been critiqued by other authors on the grounds that this assumption could not be validated easily from 
available data. Tsiatis and Davidian thus proposed a simple model in 2001 for estimating the joint model 
parameters that require no assumption on the distribution of the random effects [9]. Their approach is 
also known as the conditional score approach, whereby the random effects were considered as 
“nuisance” parameters and by conditioning on an appropriate sufficient statistic, a semiparametric 
estimator for the joint model was obtained. As expected, although the estimator could be easily 
computed by using S-Plus codes which are available from the authors, this approach is less efficient than 
parametric models.  
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 Following Tsiatis and Davidian, Song  et al. (2004)[10] also contemplated the question of the 
verifiability of  the normality assumption. They proposed to relax this assumption by requiring the 
distribution of the random effects to have a “smooth” density and used the EM algorithm for parameter 
estimation. More specifically, the density of the random effects can be represented by a 
seminonparametric estimator where the degree of flexibility of the representation can be controlled by 
a parameter K. By relaxing the normality assumption, the inference of the likelihood procedure seems to 
be unexpectedly robust and they speculated that even with misspecification of normality, the estimators 
produced by likelihood-based approach using normality will still be consistent, and this happens in their 
simulation study when K is equal to 0 or chosen via information criteria. With this finding, they thus 
concluded that their approach is useful when there is uncertainty about the distributional assumptions. 
Although the extension of their model to more complicated situations is feasible, the computational 
burden is also likely to increase with the increase in model complexity. 
 From this same perspective, Rizopoulos et al. formally investigated the effect of the 
misspecification of random effects distribution in joint modeling in 2008 [11]. The main result from their 
study shows that for certain estimators, with the increase in number of repeated measurements per 
individual, misspecification of the random effects distribution will have less effect on the inference 
procedure. On the other hand, the sandwich estimator for the estimation of the standard error is 
recommended to ensure robustness against model misspecification. 
  Besides the likelihood perspective, others have considered a Bayesian approach to the joint 
modeling problem. One of the earliest among those is the paper written by Faucett and Thomas 
published in 1998 [12]. They focused on the posterior distribution of the model parameters, which is 
estimated by using Gibbs sampling and flat priors. Gibbs sampling is a Markov Chain Monte Carlo 
(MCMC) technique which involves sampling from the full conditional distributions of each parameter 
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given the current values of all other parameters and data iteratively. This method is particularly useful 
when the joint distribution of the parameters is complicated, but sampling from each conditional 
distribution is still feasible. 
 Faucett and Thomas demonstrated their approach using simulation studies and an application 
on a dataset of immunologic markers over time and the risk of AIDS. The use of Gibbs sampling is a 
feasible approach in fitting a large model without simplifying the assumptions, but a drawback to that is 
its computational intensiveness. Assuming that the underlying model assumptions are true, this 
approach also showed a marked improvement in parameters and variance estimation with the 
incorporation of the longitudinal process model. One other strength of this approach is that even while 
relaxing the restrictive joint normality assumption on the survival times, the estimates of the variability 
still correctly reflects the uncertainty of all model parameters. However, the authors emphasized that all 
these strengths are dependent on the assumption that the underlying models and relationships were 
specified correctly, and this is one of the limitations of this approach. 
 Other authors have also considered the Bayesian approach following the publication of Faucett 
and Thomas. Wang and Taylor in 2001 [13] used MCMC to fit a joint model where an additional 
stochastic process is incorporated into the usual longitudinal model.  By including the stochastic process, 
they argued that the structure of the individual’s marker trajectories could be more flexible and 
plausible despite the added complexity to the model. Xu and Zeger (2002) [14] discussed generalizations 
of the Bayesian approach, and similarly used MCMC to estimate the parameters of the joint model in a 
clinical trial setting. 
 Most of the earlier literature on joint modeling has considered a parametric linear mixed model 
or linear stochastic model for the longitudinal process and a Cox model for the survival process. One 
disadvantage of using a parametric model for the longitudinal process is the computational burden 
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because multidimensional numerical integration is involved. Ding and Wang in 2008 [15] then came up 
with a flexible longitudinal model which is termed the nonparametric multiplicative random effects 
model where only one random effect was used to link the population mean function to the subject-
specific longitudinal profile. They proposed to approximate this population mean function using B-spline 
basis functions, and the number of knots and degrees are to be selected based on the Aikaike 
Information Criterion (AIC). Parameters estimation is performed through a modified version of EM 
algorithm, where the Monte Carlo method for random sampling was adopted in the E-step, and this 
algorithm is called the Monte Carlo Expectation Maximization (MCEM) algorithm. With only one random 
effect for each longitudinal covariate, Ding and Wang argued that this simple multiplicative model has a 
computational advantage that allows the incorporation of multiple longitudinal and time-dependent 
covariates. However, the legitimacy of using AIC or any other model selection procedure needs further 
study. 
 Another instance where the suitability of a parametric model for the longitudinal data is 
questionable is in a study of cancer recurrence in prostate cancer patients and its association to the rate 
of change in prostate-specific antigen (PSA) levels. In 2008, Ye et al. conducted such a study where the 
trajectories of the PSA levels are nonlinear and vary substantially across the subject [16]. A more flexible 
nonparametric model instead of a linear mixed model is needed and they proposed a semiparametric 
mixed model (SPMM) for the longitudinal data where the fixed effects are modeled parametrically 
whereas the individual trajectories are modeled nonparametrically using a population smoothing spline 
and subject-specific random stochastic process. As for the survival data, it is modeled by a Cox model.  
To estimate the joint model parameters, they developed a two-stage regression calibration 
approach where they maximized the partial likelihood induced by a first-order approximation of the 
conditional expectation of the longitudinal component in the hazard function. They investigated two 
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variations of the regression calibration approximation – the risk set regression calibration (RRC) method 
and the ordinary regression calibration (ORC) method. One of the strengths of this methodology is that 
it is easily implemented via available software (SAS). However, they acknowledged that the limitation of 
their methodology is that it did not take into account the informative dropouts and the uncertainty of 
measurement error. In order to overcome this limitation, the same authors came up with an estimation 
procedure based on jointly maximizing a penalized likelihood generated by Laplace approximation, in 
which the survival model can be used to model the dropout process [17]. 
Based on the literature as discussed above, joint modeling has been well studied in cohort 
studies where the longitudinal measurements were taken repeatedly for all subjects in the cohort. We 
will now turn to the specific study design of interest in our research – nested case-control. 
 
1.3 Nested Case-Control Studies & Joint Modeling 
 A nested case-control (NCC) study begins from a cohort study that was originally meant for a 
study of a specific disease where at baseline, a group of individuals free from the disease of interest 
enters the cohort. Baseline measurements are taken and these individuals are followed over time, 
where they may be asked to return for repeat visits. A participant from the cohort exits from the study 
when the individual develops the disease, dies from the disease or other unrelated causes, or simply lost 
to follow-up. In a NCC setting, controls are selected whenever a case occurs. A graphical representation 
of the NCC selection process can be seen in Figure 1.1. At time tA when a subject A is diagnosed with the 
disease, a risk set is made up of individuals who had yet to develop the disease and who matched with 
subject A on certain matching variables such as age and gender. Among those in the risk set, a certain 
number of controls will be selected randomly depending on the case-to-control ratio. In the example in 
10 
 
Figure 1.1, we randomly selected two controls for each case. This selection process will continue each 
time a case is diagnosed, and all cases and controls assembled will serve as subjects for the NCC study. 
 
 
Figure 1.1 Graphical representation of a Nested Case-Control design 
 
There are two interesting features of the NCC study. A cohort member may serve as a control for 
more than one case, and a control may also later turn out to be a case, e.g. subject E and subject G in 
Figure 1.1. In both situations, the information of such subject will be utilized only once in the analysis of 
the data. The design of a NCC study has several advantages [18] which serve as a motivation for us to 
explore joint modeling under this setting. Firstly, the smaller number of study subjects compared to a 
full cohort analysis makes it more cost-efficient and less time-consuming. For example, in a biomarkers 
study, although the blood tests of all study participants in a cohort from each follow-up examination will 
be stored, we may not have enough funding to conduct laboratory tests on the blood samples of all 
participants. However, with a NCC design, we will only need to perform the biomarkers test on only 
selected participants and this will save a considerable amount of money. Secondly, data on exposure are 
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more likely to have been collected before the event of interest occurs, and this is advantageous in 
interpreting the cause-effect relationship when association is found and recall bias is no longer an issue. 
Finally, due to the fact that both controls and cases are from the same cohort, selection bias can also be 
reduced. 
 In the statistical literature, there has not been much of a development in handling longitudinal 
covariates in a NCC study. The first paper that applied joint modeling in such a setting was published in 
2009, where they adopted the shared latent parameter framework and used the EM algorithm to 
maximize the likelihood function [19]. This paper by Tseng and Liu will be used as a basis for our own 
methodology and serve as a comparison to which the performance of our methodology will be 
evaluated upon. More details on this can be found in Chapter 2. 
 
1.4 Outline of thesis 
 Chapter 2 describes our joint modeling approach under a NCC study, where the notations used 
throughout the thesis and models involved in the joint model will be described. Chapter 3 and 4 
illustrates the application of our approach using a simulated dataset and a published dataset 
respectively. The dataset used in Chapter 4 comes from a study of patients with primary biliary cirrhosis, 




Chapter 2 Joint Modeling under Nested Case-Control Sampling 
2.1 Notation and Model Specifications 
 Like every nested case-control (NCC) design sampling, we begin with a cohort of N subjects. For 
the ith individual, baseline measurements will be taken at entry into study and we denote these 
measurements by Xi, a p x 1 vector, with p representing the number of covariates. As we follow these 
individuals throughout the study, failure or censoring will occur, and we let Ti
* be the failure time and Ci 
be the censoring time. For the purpose of analysis, we are more interested in Ti = min(Ti
*, Ci) and let Δi 
denote the censoring indicator I(Ti
*≤ Ci), which takes the value 1 if Ti
*≤ Ci or 0 otherwise. Thus, the 
observed baseline and survival profile data for the entire cohort can be denoted by (Ti, Δi, Xi). 
 A NCC study will sample for controls when a case is diagnosed. Cases refer to individuals with Δi 
=1, and when a case is diagnosed, m controls will be selected from the risk set at the failure time of the 
case. To indicate whether the ith individual from the cohort is selected into the NCC study, we use the 
notation Ri. As such, Ri = 1 for the selected cases and controls, and Ri = 0 for the rest of the cohort. 
Furthermore, longitudinal measurements of the risk factor of interest for all the NCC study subjects will 
be assembled. This is denoted by Zi = {Zij: j = 1, …, li}, where each of these measurements are taken at 
time ti = {tij: j = 1, …, li} and tij ≤ Ti. In summary, we will observe (Ti, Δi, Zi, ti, Xi) for individuals with Ri = 1 
and (Ti, Δi, Xi) for individuals with Ri = 0. 
 Our research interest is whether the trajectory of the longitudinal measurement is associated 
with the disease risk. Thus, the first thing that we must model is the change of the longitudinal 






where h(θi, tij, Xi
(1)) is the trajectory function and Xi
(1) is part of the baseline covariate vector that is 
associated with the longitudinal measurements. Xi
(1) could be reduced to an intercept if there is no such 
baseline covariates available. The error terms εij is independent and identically distributed (i.i.d) with a 
normal distribution. 
 The unobserved heterogeneity of the trajectory function among the subjects is reflected in 
equation (1) by the subject-specific random effects, θi, approximated by a multivariate normal 
distribution. The trajectory function h can take on many forms, for example, a linear function over time 
or a function that is dependent on Xi
(1) too. In our study, we focused on a linear mixed effects model and 
this will be elaborated in Chapters 3 and 4. 
 Next, to examine the association between the longitudinal measurements and survival time, we 




The independent variables in this Cox’s model are the trajectory function and Xi
(2), which is part of 
the baseline covariates associated with the survival outcome. For simplicity, we refer to Xi
(1) as the 
longitudinal covariates and Xi
(2) as the survival covariates. 
Notice that in this Cox’s model, given that the random effects were known, the hazard function no 
longer depends on the observed longitudinal measurements values Zi. The regression parameters βz and 
βx are of interest as they quantify the dependence between survival time and trajectory, and between 
survival time and the survival covariates respectively. One thing to note is that the longitudinal 
covariates may overlap with the survival covariates, and hence, we can interpret βx as the effect of Xi
(2) 
on survival time conditional on the expected value of the longitudinal measurement h(θi, t, Xi
(1)). 
The notations and model specifications of the joint modeling method that we adopted here are 
based on the paper from Tseng and Liu [19]. The parameters of interest that we want to infer are the φ 
= (βz, βx, σ
2, Σθ, λ0). Their inference method will henceforth be referred to as the full maximum likelihood 
estimation method and will be discussed in detail below. 
 
2.2 Full Maximum Likelihood Inference 
 Tseng and Liu proposed using maximum likelihood estimation (MLE) based on all observed data 
to make inferences about the parameters of interest, φ = (βz, βx, σ
2, Σθ, λ0). They argued that due to the 
fact that the sampling probabilities of controls are dependent on the observed data only, the 
unobserved longitudinal measurements of other cohort subjects not selected into the study can be 
considered as missing at random (MAR) and thus MLE will provide correct statistical inference. 




The observed-data log likelihood function is then, 
 
 The above equation shows that the log likelihood function involves a product of three different 
densities, of which the density function in the middle is only needed for the selected cases and controls. 
Based on the model specifications from the earlier section, we can determine the distribution function 
for each of these components. 
 Firstly, we will define the component in the middle as the trajectory component. From the 
sampling design of a NCC study, we know that only the history of the longitudinal measurements for 
selected subjects are assembled, and hence we will not observe this data among subjects that were not 




This is a normal distribution with mean given by the trajectory function h and variance σ2. 
 Secondly, the survival density can be derived from the hazard function to yield, 
 
 Finally, the distribution of the subject-specific random effects is as noted in the model 
specification, a multivariate normal distribution with mean 0 and variance Σθ, 
 
 Tseng and Liu proceeded on to calculate the maximum likelihood estimates using an 
expectation-maximization (EM) algorithm. For our application in Chapters 3 and 4, instead of the EM 
algorithm, we used direct maximization. However, with an integral in the log likelihood function, the 
maximum could no longer be obtained by the straightforward method of equating the derivative of the 
function to 0. Hence, we will use an approximation method called the Gaussian quadrature to replace 
the integral in the likelihood function. More details will be given in Section 2.4. 
 
2.3 Weighted Maximum Likelihood Inference 
 The full MLE method proposed by Tseng and Liu uses data not only from the selected cases and 
controls, but from all cohort subjects. One of the advantages of performing a NCC study is because we 
want to cut cost and save time by retrieving information from only the cases and sampled controls. 
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There is also a possibility that we do not have data for subjects not selected into the study. In addition to 
that, Tseng and Liu did not take into account the fact that subjects who stayed in the cohort longer have 
a higher probability of being selected into the study may be considered as a form of selection bias. In 
order to overcome the limitations of their methodology, we proposed a log likelihood function that is 
loosely based on theirs, and we called it the selected-data log likelihood function: 
 
where Ω is the set of unique selected study subjects and wi are the selection weights.  
 The idea of this weighted maximum likelihood inference is based on case-cohort data [20]. The 
selection weights in this log likelihood function will be given by the inverse of the inclusion (into the 
study) probability, denoted by pi.  For controls, the calculation of this probability is less straightforward, 
given that any subjects may be selected into the study more than once. For example, a subject may be 
selected as controls for more than one case or a control selected may later turn out to be a case. On the 
other hand, the probability of being excluded can be expressed as the union of not being selected at 
each failure time. Therefore, we can formulate the inclusion probability of the controls as, 
 
where S is the set of cases for which subject i was eligible to be selected as control for, mk is the number 
of controls selected for case k, and nk is the number of candidates in the risk set for case k. The inclusion 
probability for cases is then 1 since they are always selected into the study. 
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 Similarly, the direct maximization on this log-likelihood function involves the same integral that 
we have seen in the observed-data log-likelihood function and thus we will also use the Gaussian 
quadrature to approximate it. 
2.4 Gaussian Quadrature Approximation of the Integral 
 Generally, Gaussian quadrature simply refers to a method for calculating the area under the 
curve by splitting it up into quadrature blocks. Say, we are integrating a polynomial function f(x) of 
degree n over the interval [a, b]. We first split up [a, b] into several intervals by points a = x0 < x1 < . . .  < 
xn-1 < xn = b. The approximation can then be formulated as below: 
 
where vk is the weight given to the function valued at xk. 






 To put it in words, the original integral is now being approximated by a weighted sum of the 
product of the survival and trajectory component evaluated at the quadrature nodes uk that substitute 
the subject-specific random effects. The quadrature weights are denoted by vk. 
 In the literature, using 10 quadrature nodes or M = 10 will often give a reasonably good 
approximation of the integral. Here, we will use 20 quadrature nodes for the approximation. 
 
2.4 Standard Error Estimation 
For a typical likelihood function, we define the Fisher’s information as the expected value of the 
observed information. In our case, the Fisher’s information matrix for the observed-data log likelihood 
function is given by: 
 
The variance of the kth element of φ can then be estimated as the kth main diagonal element of 
the inverse of the Fisher’s information matrix, I-1(φ). 
However, using the same formula for our weighted analysis will underestimate our standard errors. 
This is because we are maximizing the selected-data log-likelihood function as if we have ∑ wi 
independent observations [21]. One method to obtain a robust estimator of the efficiency is through the 
use of empirical standard errors, which is calculated by taking the standard deviation of the parameter 
estimates across simulations. This calculation of the empirical standard error is applied to the simulation 
studies in Chapter 3. 
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 On the other hand, when we are applying our methods to real datasets, there will only be one 
estimate for each parameter and hence, the use of empirical standard errors as a robust evaluation of 
efficiency for the weighted analysis is not viable.  An alternative method is to use a robust sandwich 
formula to calculate the variances. 
Note that the generalized estimating equation (GEE) approach for correlated data yields 
estimating equations that are similar in form to the resulting score equation of the selected-data log 
likelihood function in equation (8) [21]. Therefore, the variances of the estimates obtained from 
maximizing the log-likelihood function can be computed using a robust sandwich formula as in the case 
with GEE estimates. This sandwich formula is given by, 
  
where I is the Fisher’s information matrix as defined in (12) and Δ is a “penalty” matrix. 
 The “penalty” matrix is to correct for the fact that we are maximizing the selected-data log 
likelihood as if we have ∑ wi independent observations. Taking the idea from Samuelsen [22], we can 
approximate Δ by, 
 
 Si(φ0) is the unweighted score vector for individual i. 
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 Again, the standard errors are taken as the square root of the variances computed from this 
formula. One thing to note is that Samuelsen’s approximation of the penalty matrix Δ was developed in 
a pseudolikelihood approach to analyze survival data under the NCC design and not meant for joint 
modeling. Thus a word of caution has to be given here: it has not been proven yet that this formula 
works for our methodology and all standard errors of the weighted estimates can only provide a rough 
gauge of the actual efficiency. One possible alternative is weighted MLE with bootstrap. However, 
nobody has thus far attempted to bootstrap NCC data as it is not well developed and understood. This is 
definitely an area for further research. The standard errors of the full MLE estimates in Chapter 4 will 
then be calculated in the usual manner, i.e. by using the inverse of the information matrix. 
 
2.5 Use of Statistical Software 
 All analysis in this study were performed on R 2.15.1 [23]. Additional package statmod [24] was 
also used  to obtain the quadrature nodes and weights used for the Gaussian quadrature approximation.
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Chapter 3 Simulation Study 
3.1 Simulation Procedure 
 To investigate the performance of the full and weighted maximum likelihood estimation (MLE) 
method as discussed in Chapter 2, we performed a simulation study using a mixture of arbitrary and real 
parameters from a published dataset. 
 The reference dataset that we used for simulation is the TwinGene cohort, which is a 
longitudinal sub-study within the Swedish Twin Register [25]. This cohort was initiated to examine 
associations between genetic factors and cardiovascular diseases among elderly Swedish twins born 
before 1958 [26]. The issue of collinearity due to twinning is avoided by using data from only one of 
every twin in this dataset. From this dataset, we obtained parameters to be used in the simulation of the 
survival and matching covariates. In addition to that, the survival coefficients are also used to generate 
the time-to-event data. As for the simulation of the longitudinal measurements, we used arbitrary 
parameters since there are no repeated measurements in this cohort. We have 7561 subjects with 
complete data in the TwinGene cohort, and hence our simulated cohort will also consists the same 
number of subjects, i.e. N = 7561. 
 Firstly, to generate the artificial longitudinal measurements Zij, we specify a linear mixed model 




 The random intercept is denoted by b0i and is generated from a normal distribution with mean 0 
and variance σb
2. The random error is denoted by εij and is generated from a normal distribution with 
mean 0 and variance σε
2. The parameters σb
2 and σε
2 are given arbitrary values 5 and 1 respectively. The 
fixed slope b1 is also arbitrarily assigned the value of 0.1. In order to generate 5 repeated measurements 
for each subject, i.e. li = 5, we assigned measurement times ti = {0, 0.1, 0.2, 0.3, 0.4} for all individuals. 
 Next, as mentioned earlier, we used parameters from the real data to simulate our matching 
variables – age and gender. Age is generated from a normal distribution with the mean and variance of 
the age of the TwinGene cohort. Gender is sampled with replacement. Both matching variables are also 
used as the survival covariates for our joint model. 
 Finally, to generate the outcome of either failure or censoring time, we used the baseline, age 
and gender survival coefficients from the real dataset. The time-to-event is generated using the inverse 
CDF method where our hazard function is now defined to be  
 
For simplicity, λ0 is a constant baseline hazard, βz is arbitrarily assigned the value 1 and Xi is the vector of 
survival covariates of age and gender. We also set the censoring time such that the number of cases in 
our simulated dataset is equivalent to the number of TwinGene subjects who experienced diabetes. 
 For our nested case-control (NCC) study design, we varied the number of controls per case from 
1 to 5. For each scenario, we simulated 100 cohorts and for every cohort, we assembled the data from 
the selected NCC subjects for the joint modeling analysis. A full cohort analysis was also performed to 
set a standard for our comparisons. In addition to that, in response to a reviewer’s comment, we also 
used a two-stage approach to analyze the simulated data. 
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3.2 Relative Efficiency 
 Using the empirical standard errors as discussed in Chapter 2, we were able to calculate the 
relative efficiency (RE) of the full and weighted MLE method to the full cohort analysis. RE is defined as 
the ratio of the empirical standard errors of the methods proposed for the NCC study design and the 
empirical standard errors obtained from the full cohort analysis. This was computed for all parameters 
and we plotted the RE’s against the number of controls per case for each of these parameters. 
 
3.3 Simulation Results 
For all four methods of analysis, we obtained the average estimates from the 100 simulations, 
the estimated standard errors based on the information matrix, and the empirical standard errors. Table 
3.1 presents the results from the simulation procedure described above with 5 controls per case.  There 
are a total of seven parameters that were estimated. From the table, we could see that the estimated 
standard errors are biased, especially for the weighted analysis. As such, comparisons will be made 







Table 3.1 Estimation result across the 100 simulation studies for the full cohort analysis, full MLE analysis, weighted MLE analysis, and two-




Full Cohort Analysis Full MLE Weighted MLE Two-stage Approach 
Par Est* 
(bias) 
Est SE* Emp SE+ 
Par Est* 
(bias) 
Est SE* Emp SE+ 
Par Est* 
(bias) 
Est SE* Emp SE+ 
Par Est* 
(bias) 
Est SE* Emp SE+ 









0.007 0.036 0.946 










0.037 0.123 -0.003 
(0.103) 0.098 0.089 









0.004 0.014 0.001 
(0.001) 0.011 0.011 









0.080 0.128 0.069 










0.144 0.207 -0.041 
(0.023) 0.138 0.117 









0.202 0.244 -1.885 










0.046 0.065 0.687 
(0.313) 0.034 0.028 
* Corresponds to the mean of these estimates (parameter and standard errors) across the 100 simulations    




With the exception of the regression parameter for survival covariate gender βgender, where even 
the full MLE estimate was far from the truth, all our weighted estimates are quite close to the true 
values. Notably for the slope parameter b1, the variance of the random error σε
2, regression parameters 
for age and trajectory βage and  βz, we can see that the bias of our weighted estimates are smaller than 
the full MLE estimates.  On the other hand, the two-stage approach produced the largest bias for almost 
all of the parameters among all four methods. 
 Besides looking at the parameter estimates, we can also compare the empirical standard errors 
from the full cohort analysis, the full MLE and weighted MLE methods. Not surprisingly, the full cohort 
estimates yielded the smallest empirical SE’s, followed by the full MLE estimates and lastly, the 
weighted MLE estimates. This loss in efficiency is not unexpected, considering that we lost a lot more 
information in the weighted analysis by not utilizing the data from subjects not selected into the NCC 
study as compared to the full cohort analysis. 
The loss in efficiency when performing a NCC study design relative to a full cohort analysis can 
be explored further by looking at the plots of relative efficiency of the beta estimates as shown in 
Figures 3.1, 3.2, and 3.3. A cubic smoothing spline with parameter of 2 is fitted to the data to obtain the 
lines in the plots. The solid line represented the RE’s of the full MLE method whereas the dashed line 
represented the RE’s of our weighted MLE method. From these plots, we can see that the RE’s of all the 
estimates do not show a steady increase with the number of controls and this is probably due to the 
sampling or simulation variability. One interesting point to note is that even with 4 or 5 controls per case, 
the relative efficiency of the full MLE method is not much higher than 1 or 2 controls per case. On the 
other hand, we can observe a much steeper slope in the plots for the weighted MLE method. Therefore, 
we can conclude that from a practical point of view, the weighted MLE method is only advisable with 4-5 
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controls. Otherwise, full MLE is recommended since the weighted method would have resulted in too 
much loss of power. Further study is needed to explain this phenomenon.  
 
 


















Figure 3.3 Plot of relative efficiency against the number of controls per case for parameter βz 
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Chapter 4 Application to the Primary Biliary Cirrhosis Dataset 
4.1 About the Dataset 
 To illustrate our methodology further, we applied the proposed approach to the primary biliary 
cirrhosis dataset obtained through the R package JM [27], which from here onwards will be referred to 
as the pbc2 dataset following the given object name in R. This dataset contains follow-up information 
from 312 randomized patients with primary biliary cirrhosis (PBC) at Mayo Clinic from January 1974 to 
April 1988 and there are a total of 20 variables available in this dataset. 
 PBC is an autoimmune disease that primarily affects women and characterized by inflammatory 
destruction of the intrahepatic bile ducts. This will then lead to decreased bile secretion and retention of 
toxic substances within the liver and eventually, liver failure. The peak incidence of this disease occurs in 
the fifth decade of life and it is rare in those below 25 years of age [28]. In this pbc2 dataset, there are a 
total of 36 males and 276 females while the minimum and mean age of the patients at baseline is 26 and 
49 respectively, corresponding to what is known about the disease.  
 Among the 312 patients in this dataset, 158 were given the drug D-penicillamine whereas the 
other 154 were randomly assigned to the placebo group. Baseline covariates, for example age and 
gender, were measured at entry time of the study.  Multiple repeated laboratory results from irregular 
follow-up visits are also available in this dataset. The original clinic protocol had specified visits at 6 
months, 1 year, and annually thereafter, but ‘extra’ visits could occasionally occur due to worsening 
medical condition. The number of visits ranges from 1 to 16, and the median number of repeated 
measurements is 5. The median interval between visits is approximately 1 year. By the end of the study, 
140 out of the 312 patients had died and the observed event time ranges from 41 to 5225 days. 
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 Several studies have been performed on this dataset [15, 29, 30], and one of which is a paper 
reviewed in Chapter 1 [15]. Among the other studies cited here, one has also established a well-known 
prognostic model which is widely used and studied in various settings [29]. In this original Mayo model 
by Dickson et al., the prediction of survival for patients with PBC are based on a risk score calculated 
from the baseline covariates. As most patients made repeated visits to the clinic, one question that we 
would like to answer is how will the repeated measurements affect the survival if a nested case-control 
(NCC) sampling is performed using this cohort and this will be explored through our approach of joint 
modeling. 
 
4.2 Covariates and the Nested Case-Control Sampling 
 In the original Mayo model, the prediction model for survival is based on age, total serum 
bilirubin value, serum albumin value, prothrombin time, and the presence or absence of edema and 
diuretic therapy. For simplicity, our joint model will only consider the repeated measurements of total 
serum bilirubin value as our longitudinal covariates, and age, gender and treatment group as our 
survival covariates. Based on the clinical literature, we performed a logarithmic transformation of serum 
bilirubin to be used for our analysis and death is defined as our event of interest. Figure 4.1 shows the 
individual log serum bilirubin trajectories for five randomly selected subjects with at least ten repeated 
measurements. 
For our study design of NCC, we chose to match individuals based on age group and gender.  The 
age of the full cohort ranges from 26 to 79, and we categorized them into 10 year age groups: 25 – 34 
years, 35 – 44 years, 45 – 54 years, 55 – 64 years, and 65 years and above. When a death occurs, one 
control from the risk set matched in the same age group and gender as the case will be selected. Using 
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this sampling design, we have a total of 209 subjects selected for our analysis. The baseline 
characteristics of our covariates in the full cohort and NCC study are shown in Table 4.1. 
 






Table 4.1 Baseline characteristics of covariates of interest in the full cohort and NCC study. Numbers 
are mean ± SD or n (%). 
Covariates 
Full Cohort Selected cases & controls 
N = 312 N = 209 
Age(years) 50.02 ±  10.58 52.28 ± 10.22 
Gender   
Male 36 (11.5%) 32 (15.3%) 
Female 276 (88.5%) 177 (84.7%) 
Treatment   
D-penicillamine 158 (50.6%) 106 (50.7%) 
Placebo 154 (49.4%) 103 (49.3%) 
(Log) Serum bilirubin (mg/dL) 0.57 ± 1.03 0.76 ± 1.07 
 
 
4.3 The Joint Model 
 For our joint model on the pbc2 dataset, we need to specify a growth curve model and a survival 
model. Similarly, we will use a linear mixed model with a fixed slope and random intercept for our 
trajectory function: 
 
where Zij are the repeated log serum bilirubin measurements, and the random intercept and random 
error are approximated by a normal distribution. The mean of the random intercept, μb, is unknown and 
has to be estimated too.  




where βbil is the regression parameter for the log serum bilirubin trajectory and βx = (βage, βsex, βdrug) are 
the regression parameters for the survival covariates age, gender and treatment. For simplicity, we 
assumed that the baseline hazard is a constant. 
 
4.4 Results of the Application 
Table 4.2 shows the result of our joint modeling approach on the NCC subset of the pbc2 data. In 
addition to that, we also performed simple survival analyses using available measurement of log serum 
bilirubin that is taken closest to the time of the event. The purpose of the simple survival analyses is to 
illustrate how the application of our methodology serves our motivation of modeling the longitudinal 
outcome that occurs at the specific event time in order to have a more accurate representation of its 
effect on survival. Besides this measurement, covariates age, gender and treatment are also included to 
mimic the Cox’s model of our joint model. We performed the simple survival analyses both on the full 
cohort and the selected cases and controls. Note that the full cohort analysis in this chapter is different 
from the full cohort analysis in Chapter 3 where we used the joint modeling approach on the full cohort. 
The standard errors for the joint modeling approach were estimated using the robust sandwich formula 
as discussed in Chapter 2, whereas the standard errors for the simple survival analyses were estimated 
from the information matrix. 
  From this table, we see that covariates age and closest measurement of log serum bilirubin have 
significant effects on the survival of PBC patients and the estimates of the subset does not differ much 
from the estimates of the full cohort. Similarly to the simple survival analyses, only the covariate age and 
the trajectory of the log serum bilirubin levels show significant association to the survival of selected 
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cases and controls. In terms of effect size, we see that the full and weighted maximum likelihood 
estimation (MLE) method yield estimates that are closer to the estimate for the full cohort for the 
regression parameter for age. On the other hand, by modeling the trajectory of the log serum bilirubin 
level, we observed that the effect size of this variable is larger than the effect size of the closest 
available measurement. This implies that the analysis using the closest available measurement of the 
longitudinal covariate lacks the power to detect the effect of the exposure on survival unlike the joint 
modeling approach. 
Now for the comparison between the full and weighted MLE estimates, we see that there is not 
much difference between the two estimates for significant regression parameters βage and βbil. In 
addition to that, the variance of the random error, the baseline hazard, and the mean of the subject-
specific random effect has quite similar full and weighted MLE estimates. The standard errors of the 
weighted estimates are also lower than that of the full MLE estimates, suggesting that the robust 




Table 4.2 Full and weighted MLE estimates from joint modeling approach and estimates using simple survival analyses 
 
Parameters 
Full MLE*  Weighted MLE* Full Cohort+ Selected cases & controls+ 
Estimates (SE) p-value Estimates (SE) p-value Estimates (SE) p-value Estimates (SE) p-value 
ln σb -0.090 (0.022) <0.001 -0.015 (0.015) <0.001 N.A.  N.A.  N.A.  N.A.  
b1 0.116 (0.005) <0.001 0.091 (0.002) <0.001 N.A.  N.A.   N.A.  N.A.  
ln σε -0.655 (0.021) <0.001 -0.696 (0.015) <0.001 N.A.   N.A.  N.A.  N.A.  
βdrug -0.087 (0.189) 0.646 0.039 (0.178) 0.626 -0.022 (0.171) 0.898 -0.022 (0.170) 0.899 
βage 0.060 (0.009) <0.001 0.065 (0.009) <0.001 0.054 (0.009) <0.001 0.036 (0.009) <0.001 
βsex 0.005 (0.249) 0.983 0.176 (0.246) 0.983 0.244 (0.234) 0.297 0.305 (0.229) 0.182 
ln c -7.438 (0.677) <0.001 -7.710 (0.637) <0.001 -6.809 (0.619) <0.001 -5.329 (0.618) <0.001 
βbil 1.383 (0.123) <0.001 1.313 (0.108) <0.001 0.788 (0.078) <0.001 0.633 (0.078) <0.001 
µb 0.729 (0.036) <0.001 0.681 (0.023) <0.001 N.A.  N.A.  N.A.  N.A.  
* Joint modeling approach 




Chapter 5 Discussion 
 A nested case-control (NCC) study is desirable when we want to save cost and time. In this thesis, 
we have presented a joint model that can be used to analyze data from such a study design. Our model 
comprises of a longitudinal component and a survival component as in many joint modeling approaches 
that were applied to cohort studies described in the literature review in Chapter 1. Our study can be 
considered among the earliest that looked at the implementation of joint modeling in a NCC design. We 
modeled the longitudinal data using a mixed effects model that can explain the heterogeneity of the 
trajectory among the study subjects with unobserved random effects. The survival component is then 
modeled by a Cox’s proportional hazards model with time-dependent covariates to investigate the 
association between the exposure trajectory and disease survival. We then derived the likelihood 
functions based on these model specifications whereby the parameters of interest can be inferred from 
it through direct maximization. 
 In Chapter 2, we have elaborated on the maximum likelihood inference methods that we used 
on the simulation study and the real data application. The first method that we discussed was based on 
a paper by Tseng and Liu [19] and uses observed data from all cohort subjects. For selected cases and 
controls, all relevant measurements are available, and for subjects not selected into the NCC study, they 
have argued that only the survival and baseline information are available. However, this may not hold 
true in certain scenarios. For example, there is an existing ongoing cohort study led by another team of 
investigators and at a certain point in the study, we request for a collaboration to perform a NCC study 
on the cohort. The request for additional data for subjects not selected into the NCC study may involve 
certain procedure fees which we may not budgeted for, or the research team may not be able to share 
information of the full cohort due to IRB restrictions. Therefore, we will only be able to gather data for 
our selected cases and controls in this scenario and the full maximum likelihood inference may not be 
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feasible. Hence, we proposed a weighted maximum likelihood inference method that can then be used 
when we are limited in terms of the information on subjects not selected into the NCC study. 
 Next, we showed the application of these approaches on a simulation study and a real dataset in 
Chapters 3 and 4. The primary aim of the simulation study in Chapter 3 was to compare the 
performance of the full maximum likelihood estimation (MLE) and the weighted MLE methods. We also 
performed a full cohort analysis to serve our secondary aim of investigating how the estimates of the 
NCC study hold against the full cohort. The results in Table 3.1 showed that almost all of the weighted 
estimates are generally unbiased. When compared with the full MLE estimates, we also noticed that 
certain parameters have even smaller bias. We used the empirical standard errors as a more robust way 
of evaluating efficiency as it was shown in the table that the estimated standard errors from the Fisher’s 
information matrix are biased. When compared to the full cohort, both the MLE methods for NCC study 
underperform in this area. Specifically, the weighted MLE estimates have larger standard errors than the 
full MLE estimates and lower relative efficiency (RE) as shown in Figures 3.1, 3.2, and 3.3. 
 In summary, the results from the simulation study showed that it is preferable to perform a full 
cohort analysis when data is available for all cohort subjects. When we are limited by the amount of 
time and funding, we can use a NCC design to select a smaller subset of subjects for analysis. If the 
information of the full cohort is available, the full MLE method would be a better option as it has larger 
power and higher efficiency. But in the case where only the data for the selected subset is available, we 
will have to turn to the weighted MLE method or the two-stage approach for inference. However, it has 
also been shown in Table 3.1 that the two-stage approach will produce large bias in and therefore, the 
weighted MLE method is still the recommended approach for this type of analysis. Although the 
weighted MLE approach may not be as efficient as the full MLE method due to the loss of information of 
other cohort subjects, the results in Chapter 3 showed that it is able to produce estimates that are 
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almost as good as the full MLE estimates. Furthermore, we will be able to save time by analyzing a 
smaller subset of data compared to the full MLE method. 
 Moving on to Chapter 4 where we applied our methodology to the real data of patients with 
primary biliary cirrhosis (PBC). The original cohort is made up of 312 patients and we sampled the cohort 
for our NCC setting by a case-to-control ratio of 1:1 and matching by age group and gender. The 
resulting NCC subset has 209 subjects with 140 cases. Table 4.1 showed that the baseline characteristics 
of the covariates of interest do not differ much between the original cohort and the NCC subset. In 
addition to evaluating the performance of the weighted MLE estimates against the full MLE estimates, 
we also hope to show that modeling the trajectory will help in quantifying the association between the 
longitudinal outcome and survival more accurately. By plotting the trajectories of the log serum bilirubin 
levels of five randomly selected subjects in this dataset as shown in Figure 4.1, we are able to note that 
the change in this longitudinal outcome is not linear. Hence, it will not be suffice to use the 
measurement taken at the time closest to the event as a covariate for the survival analysis as mentioned 
in Chapter 1. Nevertheless, we performed such a survival analysis to contrast the result of that to our 
joint model and this was done separately in the original cohort and our NCC subset.  
 Through Table 4.2, we see that the added advantage of modeling the trajectory of the 
longitudinal data and survival simultaneously is that the effect size of the modeled longitudinal outcome 
is actually larger than when we used the closest measurement as a proxy. This implies that the closest 
measurement did not really reflect the true value of the longitudinal exposure at the time of event. By 
comparing the full MLE and weighted MLE estimates, we also noted that not all of the parameters have 
similar value where there is some discrepancy in the values of the subject-specific random effects and 
the not significant regression parameters for gender and treatment.  
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 For the real data application, the calculation of empirical standard errors is impossible and we 
proposed a robust sandwich formula in equation (14) for estimating the variances of the estimates. The 
sandwich formula has its roots in the generalized estimating equations (GEE) approach [21] and it 
involves a penalty matrix. The idea for the approximation of this penalty matrix is then taken from a 
pseudolikelihood approach to analyze survival data in NCC studies [22]. To the best of our knowledge, 
no such approximation has been developed yet for joint modeling in NCC studies, and in Tseng and Liu’s 
paper, they used the EM-aided numerical differentiation of the profile likelihood as proposed by another 
pair of authors [31] for the estimation of the standard errors. For simplicity, we proceeded with the 
computation of the standard errors for the weighted estimates using the robust sandwich formula but 
the results in Table 4.2 indicated that this formula may not be entirely appropriate. This is because 
contrary to what we found in the simulation study, the standard errors of the weighted MLE estimates 
are now smaller than that of the full MLE estimates and we admit that further investigation is needed. 
The benefits of the joint approach can be noted clearly from this chapter where we know that in 
real applications, the longitudinal covariates are often collected with measurement errors or with 
missingness. In this situation, it is highly unlikely that we will be able to linearly extrapolate the 
fluctuation of these covariates and we have no way to gauge the accuracy of using the closest 
measurement to represent the actual exposure value experienced immediately before the event. 
Marginal approach such as the two-stage method has been noted to be biased in the literature and also 
through our simulation study as there will be uncertainties not accounted for in the separate modeling 
of the survival and longitudinal outcome. Joint modeling, on the other hand, will take into account all 




In general, joint modeling is an attractive approach to analyze NCC studies with longitudinal 
measurements. It has the advantage of being able to evaluate the association between the disease and 
time-dependent exposure while existing methods for such study design [32, 33] can only handle time-
invariant exposures. Besides that, both the full and weighted MLE methods can be directly applied to a 
case-cohort study design since the likelihood function will be the same. Our methodology of weighted 
analysis has the strength of being time- and cost-efficient as compared to Tseng and Liu’s methodology 
due to the fact that we do not need information from all cohort subjects and consequently, we are 
analyzing a smaller dataset which also saves computational time and burden. Although the efficiency of 
the weighted MLE is not as good as the full MLE method, we will still be able to estimate the parameters 
with similar value when we are limited by the availability of data and time and hence, the importance of 
our methodology should not be taken lightly. 
 On the other side of the coin, we have certain limitations to our study that needs further 
improvement. Firstly, the use of direct maximization as opposed to the expectation-maximization (EM) 
algorithm employed by Tseng and Liu will increase the computational burden especially when there are 
many parameters to be estimated in the joint model. Secondly, the normality assumption for the 
random effects or residuals may be too rigid but this can be easily overcome by modifying our model 
using nonparametric random effects proposed by a few papers discussed in Chapter 1 [9, 10] but this is 
beyond the scope of this thesis. Thirdly, the modeling of the longitudinal data may require some prior 
knowledge regarding its trajectory. In both our simulation study and data application, we used a linear 
mixed model with random intercept as our trajectory function, but other forms such as a linear function 
of time or a random slope and intercept mixed model can also be considered. Finally, our methodology 
focuses on one survival outcome but in reality, there may be more than one competing risks that causes 
the study subjects to exit from the study. This was discussed by Elashoff et al. who came up with a joint 
model  of repeated measurements and competing risks failure time data [34] which we could probably 
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use as a reference to extend our method. Other extensions that incorporate the possibility of cure [35-
37] or the accelerated failure time model [38] are also useful alternatives to our proposed method. 
 Further studies are needed for the proposed solutions to the above shortcomings of our 
methodology. In addition to that, more research is also needed on the approximation of the penalty 
matrix in the robust sandwich formula for the standard errors of the weighted analysis. One other future 
research direction that we hope to take is to look into the possibility of clustering individuals with similar 
trajectories and to examine how these clusters affect survival. Unlike the proposed method in this thesis 
where the association of the longitudinal data and survival are based on the individual trajectories, 
clustering may be able to cancel out unwanted “noise” and enable us to capture the true underlying 
behavior that influences the survival outcome. This, in accordance to the mission of our school, will 
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R codes for the simulation and analysis of NCC study (5 controls per case) 
 
####=============================#### 
#### Simulation & analysis of NCC study #### 
####=============================#### 
 
setwd('F:/MSc Related/Nested Case-Control') 
cohort.est = matrix(0,100,7) 
cohort.se = matrix(0,100,7) 
full.est = matrix(0,100,7) 
full.se = matrix(0,100,7) 
wt.est = matrix(0,100,7) 
wt.se = matrix(0,100,7)  
 
 




real.data = read.csv('F:/MSc Related/Nested Case-Control/twingene4R.csv',header=T) 
# use only those without missing covariates 
real.data = real.data[!is.na(apply(real.data[,1:11],1,mean)),] 
real.data$sex=real.data$sex-1 
 
## The whole simulation repeats for M times  




# get survival coef (out3b object) 
load('F:/MSc Related/Nested Case-Control/exp_semipar_twingene_bestresult.rdata') 
 
for(iter in 1:M) { 
 
n = nrow(real.data) 
 




# matching vars 
gender = sample(0:1,size=n,replace=T,prob=c(1-mean(real.data$sex),mean(real.data$sex))) 
age = round(rnorm(n,mean=mean(real.data$age),sd=var(real.data$age)^0.5)) 
scale.age = scale(age) 
mvar.matrix = as.matrix(cbind(1,gender,age)) 
 
# collate data 
data = data.frame(age=scale.age,gender)   
 
##- Generate time of event / censoring -## 
##-------------------------------------------------## 
 
b0i.all = rnorm(n, 0, sqrt(5)) # generate random intercept for ALL individuals 
u =runif(n) # generate random unif number needed to generate time to events. 
surv.coef = out3b$p[c(7,9,12)] # coef for baseline, age, gender 
# generate time to events  using Cox'PH model with constant baseline hazards 
# beta.z = 1, b1 = 0.1 
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log.form = 1 - ((1*0.1/exp(surv.coef[1]))*(log(1-u)/exp(b0i.all +   
  as.matrix(data) %*% as.matrix(surv.coef[-1])))) 
t = (1 / (1*0.1)) * log(log.form)  
 
 
data = data.frame(data,t) 
 
# determine end of follow-up so that nevents = no of diab events in twingene 
time.stop=sort(t)[sum(real.data$diab_ev)] 
 
# event indicator variable 
y <- as.numeric(data$t<=time.stop) 
data <- cbind(data, y) 
data$t2 = ifelse(data$t>time.stop,time.stop,data$t) 
 
 




## sd for random intercept = sqrt(5) 
## sd for epsilon = 1 
## fixed slope = 0.1 
time.long = c(0, 0.1, 0.2, 0.3, 0.4) 
eps.long = matrix(rnorm(n*5, 0, 1),n,5) 
long.meas = matrix(NA, n, 5) 
 
for (i in 1:n){ 
 for (j in 1:5){ 
  if (time.long[j] <= data$t2[i]){ 
   long.meas[i,j] = b0i.all[i] + time.long[j]*0.1 + eps.long[i,j] 




full.data = as.matrix(cbind(data, long.meas)) 
 




data = data.frame(full.data[,1:3]) 
id = 1:n 
case1 = id[t<=time.stop] 
nc1 = 5 # no. of controls per case 
ncase = length(case1) 
strata1 = array(0,dim=c(ncase,nc1+1)) 
slct.id = array(0,dim=c(ncase,nc1+1)) 
prob.vec = rep(1,n) 
#cc.data = cbind(y=1,y2=1,data[1,],id=1,weight=1) 
for(i in 1:ncase) { 
   candi = id[data$t>data$t[case1[i]] & data$gender==data$gender[case1[i]] & abs(data$age-
data$age[case1[i]])==0] 
   if(length(candi)>1) { 
     slct.id[i,1:(min(length(candi),nc1)+1)] = c(case1[i],sample(candi,size=min(length(candi),nc1))) 
     strata1[i,1:(min(length(candi),nc1)+1)] = rep(i,min(length(candi),nc1)+1) 
     prob.vec[candi] = prob.vec[candi] * (1-min(length(candi),nc1)/length(candi)) 
   } 
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   if(length(candi)==1) { 
     slct.id[i,1:2] = c(case1[i],candi) 
     strata1[i,1:2] = rep(i,2) 
     prob.vec[candi] = prob.vec[candi] * (1-min(length(candi),nc1)/length(candi)) 
   } 
 
 
   if(length(candi)==0) { 
     slct.id[i,1] = case1[i] 
     strata1[i,1] = i 




# calculate incl prob as 1- prob.vec 
incl.prob = 1 - prob.vec 
incl.prob[c(slct.id[,1])] = 1 




# Selected subjects' ID 
study1.id <-  c(c(t(slct.id[,1:(nc1+1)]))) 
study1.id = study1.id[study1.id>0] 
# get rid of duplicates 
study1.id = na.omit(study1.id[!duplicated(study1.id)]) 
 
# Selected and unselected data matrix 
cc.data = as.matrix(full.data[c(study1.id),]) 
cc.data = cbind(cc.data, wt.vec[study1.id]) 
unslct.data = as.matrix(full.data[-c(study1.id),c(1:5)]) 
 
######################## 







source('WeightedMLE.r')   
 
# starting values 
p.ini = c(0.8, 0.1, 0, 0.2, -0.02, -4.93, 1 ) 
 
# Cohort estimates 
out.c = optim(par=p.ini, fn=cohort.mle, full.data=full.data, m=20, hessian=T, method="BFGS") 
cohort.est[iter,]=out.c$p 
cohort.se[iter,] = (diag(solve(out.c$hess))^0.5) 
 
# Full MLE function 
out.f=optim(par=p.ini, fn=full.mle, unslct.data=unslct.data, cc.data=cc.data, 
  m=20, hessian=T,method="BFGS") 
full.est[iter,]=out.f$p 
full.se[iter,] = (diag(solve(out.f$hess))^0.5) 
 
# Weighted MLE function 
out.w=optim(par=p.ini, fn=weight.mle, cc.data=cc.data, m=20, hessian=T, 
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  method="BFGS") 
wt.est[iter,]=out.w$p 
wt.se[iter,] = (diag(solve(out.w$hess))^0.5) 
 
print(iter) #print(par[iter,]) 
print(c(out.c$convergence, out.f$convergence, out.w$convergence)) 
print(time.stop) 
print(table(full.data[,4])) #print number of cases & controls 
 
} # end of m 
 
# Full cohort 
par.est =  apply(cohort.est,2,mean) 
est.se =  apply(cohort.se,2,mean) 







# Full MLE  
par.est =  apply(full.est,2,mean) 
est.se =  apply(full.se,2,mean) 





# Weighted MLE  
par.est =  apply(wt.est,2,mean) 
est.se =  apply(wt.se,2,mean) 








R function of the MLE on full cohort data 
####=============#### 




#### On full cohort data #################################################### 
######## 1st 2 vars: age, gender (cov assoc with survival) ######################### 
######## Vars 3-5: t (time to event), y2 (event), t2 (Ti) ########################### 
######## Vars 6-10: longitudinal measurements ################################ 
######################################################################## 
 
#- Likelihood function for optim -# 
#----------------------------------------# 
 
# m: number of quadrature points 






cohort.mle = function(p, full.data, m){ 
 
 quad.weights = gauss.quad.prob(m,dist='normal',sigma=exp(p[1]))$weights 
 quad.nodes = gauss.quad.prob(m,dist='normal',sigma=exp(p[1]))$nodes 
 
 long.meas = full.data[,c(6:10)] 
 time.long = c(0, 0.1, 0.2, 0.3, 0.4) 
 surv.cov = full.data[, c(1:2)] 
 event = full.data[, 4] 
 Ti = full.data[, 5] 
 quad.sum = 0 
 
 for (k in 1:m){ 
 




  ## Trajectory component for selected cases and controls 
  # normal density for longitudinal measurements 
  traj.dist1 = dnorm(long.meas[,1], b.rand + p[2]*time.long[1], exp(p[3])) 
  traj.dist2 = dnorm(long.meas[,2], b.rand + p[2]*time.long[2], exp(p[3])) 
  traj.dist3 = dnorm(long.meas[,3], b.rand + p[2]*time.long[3], exp(p[3])) 
  traj.dist4 = dnorm(long.meas[,4], b.rand + p[2]*time.long[4], exp(p[3])) 
  traj.dist5 = dnorm(long.meas[,5], b.rand + p[2]*time.long[5], exp(p[3])) 
 
  # replace NA values to be 1 for cumulative product to be calculated 
  traj.dist2 = replace(traj.dist2, which(is.na(traj.dist2)), 1) 
  traj.dist3 = replace(traj.dist3, which(is.na(traj.dist3)), 1) 
  traj.dist4 = replace(traj.dist4, which(is.na(traj.dist4)), 1) 
  traj.dist5 = replace(traj.dist5, which(is.na(traj.dist5)), 1) 
 
  # Cumulative product of normal density for each indiv 




  ## Survival component for selected cases and controls 
  # Set up parameters for coefficients for survival covariates 
  beta.x = t(as.matrix(c(p[4:5]))) 
  surv.func = (exp(p[6])/(p[7]*p[2]))*exp(p[7]*b.rand + beta.x%*%t(surv.cov))* 
   (exp(p[7]*p[2]*Ti) - 1) 
 
  haz.func = (exp(p[6])*exp(p[7]*(b.rand + p[2]*Ti) + beta.x%*%t(surv.cov))) 
  surv.comp = ((haz.func)^event) * exp(-surv.func) 
 
  ## Evaluate integral at k-th quadrature points and summing up 
  int.like = traj.comp * surv.comp * quad.weights[k] 













R function of the Full MLE for simulation studies 
####==================================#### 




#### Using simplest scenario ######################################### 
######## unslct.data: data frame for unselected indiv #################### 
######## cc.data: data frame for selected indiv ######################### 
######## 1st 2 vars: age, gender (cov assoc with survival) ################# 
######## Vars 3-5: t (time to event), y2 (event), t2 (Ti) #################### 
######## Vars 6-10 (cc.data): longitudinal measurements ##### ############ 
################################################################# 
 





# m: number of quadrature points 




full.mle = function(p, unslct.data, cc.data, m){ 
 
 quad.weights = gauss.quad.prob(m,dist='normal',sigma=exp(p[1]))$weights 
 quad.nodes = gauss.quad.prob(m,dist='normal',sigma=exp(p[1]))$nodes 
 
 long.meas = cc.data[,c(6:10)] 
 time.long = c(0, 0.1, 0.2, 0.3, 0.4) 
 surv.cov1 = cc.data[, c(1:2)] 
 surv.cov2 = unslct.data[,c(1:2)] 
 event1 = cc.data[, 4] 
   event2 = unslct.data[, 4] 
 Ti.1 = cc.data[, 5] 
 Ti.2 = unslct.data[, 5] 
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 quad.sum1 = 0 
 quad.sum2 = 0 
 
 for (k in 1:m){ 
 
      b.rand = quad.nodes[k] 
 
      ## Trajectory component for selected cases and controls 
      # normal density for longitudinal measurements 
      traj.dist1 = dnorm(long.meas[,1], b.rand + p[2]*time.long[1], exp(p[3])) 
      traj.dist2 = dnorm(long.meas[,2], b.rand + p[2]*time.long[2], exp(p[3])) 
      traj.dist3 = dnorm(long.meas[,3], b.rand + p[2]*time.long[3], exp(p[3])) 
      traj.dist4 = dnorm(long.meas[,4], b.rand + p[2]*time.long[4], exp(p[3])) 
      traj.dist5 = dnorm(long.meas[,5], b.rand + p[2]*time.long[5], exp(p[3])) 
 
      # replace NA values to be 1 for cumulative product to be calculated 
      traj.dist2 = replace(traj.dist2, which(is.na(traj.dist2)), 1) 
      traj.dist3 = replace(traj.dist3, which(is.na(traj.dist3)), 1) 
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      traj.dist4 = replace(traj.dist4, which(is.na(traj.dist4)), 1) 
      traj.dist5 = replace(traj.dist5, which(is.na(traj.dist5)), 1) 
 
      # Cumulative product of normal density for each indiv 
      traj.comp = traj.dist1 * traj.dist2 * traj.dist3 * traj.dist4 * traj.dist5 
 
      ## Survival component for selected cases and controls 
      # Set up parameters for coefficients for survival covariates 
      beta.x = t(as.matrix(c(p[4:5]))) 
      surv.func = (exp(p[6])/(p[7]*p[2]))*exp(p[7]*b.rand + beta.x%*%t(surv.cov1))* 
         (exp(p[7]*p[2]*Ti.1) - 1) 
 
      haz.func = (exp(p[6])*exp(p[7]*(b.rand + p[2]*Ti.1) + beta.x%*%t(surv.cov1))) 
      surv.comp = ((haz.func)^event1) * exp(-surv.func) 
 
      ## Evaluate integral at k-th quadrature points and summing up 
      int.like1 = traj.comp * surv.comp * quad.weights[k] 




      ## Survival component for unselected individuals 
      surv.func = (exp(p[6])/(p[7]*p[2]))*exp(p[7]*b.rand + beta.x%*%t(surv.cov2))* 
         (exp(p[7]*p[2]*Ti.2) - 1) 
 
      haz.func = (exp(p[6])*exp(p[7]*(b.rand + p[2]*Ti.2) + beta.x%*%t(surv.cov2))) 
      surv.comp = ((haz.func)^event2) * exp(-surv.func) 
 
      ## Evaluate integral at k-th quadrature points and summing up 
      int.like2 = surv.comp * quad.weights[k] 
      quad.sum2 = quad.sum2 + int.like2 
 
     } 
 
     quad.sum1 = log(quad.sum1) 
     quad.sum2 = log(quad.sum2) 
     logl.mat = c(quad.sum1, quad.sum2) 









R function of the Weighted MLE for simulation studies 
####=======================#### 




#### Only includes selected individuals ######################################## 
######## cc.data: data frame for selected indiv ################################# 
######## 1st 2 vars: age, gender (cov assoc with survival) ######################### 
######## Vars 3-5: t (time to event), y2 (event), t2 (Ti) ########################### 
######## Vars 6-10: longitudinal measurements ##### ########################### 
######## Var 11: Weights (inverse of prob of inclusion) ########################## 
######################################################################## 
 





# m: number of quadrature points 




weight.mle = function(p, cc.data, m){ 
 
 quad.weights = gauss.quad.prob(m,dist='normal',sigma=exp(p[1]))$weights 
 quad.nodes = gauss.quad.prob(m,dist='normal',sigma=exp(p[1]))$nodes 
 
 long.meas = cc.data[,c(6:10)] 
 time.long = c(0, 0.1, 0.2, 0.3, 0.4) 
 surv.cov = cc.data[, c(1:2)] 
 event = cc.data[, 4] 
 Ti = cc.data[, 5] 
 wt = cc.data[,11] 




 for (k in 1:m){ 
 
      b.rand = quad.nodes[k] 
 
      ## Trajectory component for selected cases and controls 
      # normal density for longitudinal measurements 
      traj.dist1 = dnorm(long.meas[,1], b.rand + p[2]*time.long[1], exp(p[3])) 
      traj.dist2 = dnorm(long.meas[,2], b.rand + p[2]*time.long[2], exp(p[3])) 
      traj.dist3 = dnorm(long.meas[,3], b.rand + p[2]*time.long[3], exp(p[3])) 
      traj.dist4 = dnorm(long.meas[,4], b.rand + p[2]*time.long[4], exp(p[3])) 
      traj.dist5 = dnorm(long.meas[,5], b.rand + p[2]*time.long[5], exp(p[3])) 
 
      # replace NA values to be 1 for cumulative product to be calculated 
      traj.dist2 = replace(traj.dist2, which(is.na(traj.dist2)), 1) 
      traj.dist3 = replace(traj.dist3, which(is.na(traj.dist3)), 1) 
      traj.dist4 = replace(traj.dist4, which(is.na(traj.dist4)), 1) 




      # Cumulative product of normal density for each indiv 
      traj.comp = traj.dist1 * traj.dist2 * traj.dist3 * traj.dist4 * traj.dist5 
 
      ## Survival component for selected cases and controls 
      # Set up parameters for coefficients for survival covariates 
      beta.x = t(as.matrix(c(p[4:5]))) 
      surv.func = (exp(p[6])/(p[7]*p[2]))*exp(p[7]*b.rand + beta.x%*%t(surv.cov))* 
         (exp(p[7]*p[2]*Ti) - 1) 
 
      haz.func = (exp(p[6])*exp(p[7]*(b.rand + p[2]*Ti) + beta.x%*%t(surv.cov))) 
      surv.comp = ((haz.func)^event) * exp(-surv.func) 
 
      ## Evaluate integral at k-th quadrature points and summing up 
      int.like = traj.comp * surv.comp * quad.weights[k] 
      quad.sum = quad.sum + int.like 
 




     logl.mat = log(quad.sum) * wt 
     -sum(logl.mat) 
 




R codes for calculation and plotting of the relative efficiency 
###=======================#### 
### Calculate relative efficiency #### 
###=======================#### 
 
setwd('F:/MSc Related/Nested Case-Control ') 
 
################################ 




emp.c =  apply(cohort.est,2,sd) 
emp.f =  apply(full.est,2,sd) 
emp.w =  apply(wt.est,2,sd) 
 
re.full = emp.c / emp.f 
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re.wt = emp.c / emp.w 
 
nc1.re = cbind(round(re.full,3), round(re.wt,3)) 
rm(cohort.est, cohort.se, full.est, full.se, wt.est, wt.se) 
 
############################### 




emp.c =  apply(cohort.est,2,sd) 
emp.f =  apply(full.est,2,sd) 
emp.w =  apply(wt.est,2,sd) 
 
re.full = emp.c / emp.f 
re.wt = emp.c / emp.w 
 




rm(cohort.est, cohort.se, full.est, full.se, wt.est, wt.se) 
 
############################### 




emp.c =  apply(cohort.est,2,sd) 
emp.f =  apply(full.est,2,sd) 
emp.w =  apply(wt.est,2,sd) 
 
re.full = emp.c / emp.f 
re.wt = emp.c / emp.w 
 
nc3.re = cbind(round(re.full,3), round(re.wt,3)) 
 









emp.c =  apply(cohort.est,2,sd) 
emp.f =  apply(full.est,2,sd) 
emp.w =  apply(wt.est,2,sd) 
 
re.full = emp.c / emp.f 
re.wt = emp.c / emp.w 
 
nc4.re = cbind(round(re.full,3), round(re.wt,3)) 
 









emp.c =  apply(cohort.est,2,sd) 
emp.f =  apply(full.est,2,sd) 
emp.w =  apply(wt.est,2,sd) 
 
re.full = emp.c / emp.f 
re.wt = emp.c / emp.w 
 
nc5.re = cbind(round(re.full,3), round(re.wt,3)) 
 
rm(cohort.est, cohort.se, full.est, full.se, wt.est, wt.se) 
 
re.result = cbind(nc1.re, nc2.re, nc3.re, nc4.re, nc5.re) 
 





### Plot RE graph for inclusion in thesis #### 
###=============================#### 
## Select beta estimates only 
 
full.re = re.result[c(4,5,7),c(1,3,5,7,9)] 





## Par: beta_age ## 
################ 
 
plot(NA, ylim=c(0,1), xlim=c(1,5),xlab = "Number of controls per case",  
 ylab = "Relative Efficiency") 






age.full = smooth.spline(c(1:5),full.re[1,]) 





legend("bottomright", c("Full MLE", "Weighted MLE"), lty=c(1,2),  
 title = "Legend") 
 
################### 
## Par: beta_gender ## 
################### 
 
plot(NA, ylim=c(0,1), xlim=c(1,5),xlab = "Number of controls per case",  
 ylab = "Relative Efficiency") 
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sex.full = smooth.spline(c(1:5),full.re[2,]) 





legend("bottomright", c("Full MLE", "Weighted MLE"), lty=c(1,2),  
 title = "Legend") 
 
############## 
## Par: beta_z ## 
############## 
 
plot(NA, ylim=c(0,1), xlim=c(1,5),xlab = "Number of controls per case",  
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 ylab = "Relative Efficiency") 




z.full = smooth.spline(c(1:5),full.re[3,]) 





legend("bottomright", c("Full MLE", "Weighted MLE"), lty=c(1,2),  




R codes for the analysis of the PBC dataset 
####====================================#### 
#### Selecting cases and controls from pbc2 data #### 
####====================================#### 
 
setwd('F:/MSc Related/Nested Case-Control/pbc2') 
library(JM) 
 
##-- Selection of variables & conversion to wide format --## 
##============================================## 
 
## Selecting variables of interest 
pbc2.dat = pbc2[,c(1:7,12,20)] 
 
## Converting data from long to wide format 
uniq.id = rle(c(pbc2.dat$id)) 




for(i in 1:length(uniq.id$value)){ 
 
 t = uniq.id$length[i] 




pbc2.dat = cbind(pbc2.dat, t.meas) 
 
colnames(pbc2.dat)[c(7,8,10)] = c("t.meas", "bilir", "meas.t") 
 
pbc2.w = reshape(pbc2.dat, idvar = "id", v.names = c("t.meas","bilir"),  
 timevar = "meas.t", direction = "wide", sep="")  
 
## Re-order columns 





## Check number of repeated measurements 
summary(uniq.id$length) 
 
age = pbc2.w$age 
sex = pbc2.w$sex 
stat = pbc2.w$status2 
year = pbc2.w$years 
drug = pbc2.w$drug 
 
## To categorize age into 10-year agegroup 
agegrp = ceiling((age - 25) / 10) 
agegrp = replace(agegrp, which(agegrp == 6), 5) 
 
## Recode drug and sex to be numeric 
sex = as.vector(sex); drug = as.vector(drug) 
sex = replace(sex, which(sex=="male"), 0) 
sex = replace(sex, which(sex=="female"), 1) 
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pbc2.w$sex = as.numeric(sex) 
 
drug = replace(drug, which(drug=="placebo"), 0) 
drug = replace(drug, which(drug=="D-penicil"), 1) 
pbc2.w$drug = as.numeric(drug) 
 
## Selecting the closest available serum bilirubin 
bilir.t = pbc2.w[,c(24:39)] 
bilir.T = abs(year - bilir.t) 
closest.meas = apply(bilir.T, 1, which.min) 
 
bil.long = pbc2.w[,c(8:23)] 
 
bilir = NULL 
 
for(i in 1: nrow(bil.long)){ 









##-- Case-control selection --## 
##============================## 
 
n = nrow(pbc2.w) 
 
id = 1:n 
case1 = id[stat == 1] 
nc1 = 1 
ncase = length(case1) 
strata1 = array(0,dim=c(ncase,nc1+1)) 
slct.id = array(0,dim=c(ncase,nc1+1)) 




for(i in 1:ncase) { 
   candi = id[year>year[case1[i]] & sex==sex[case1[i]] & agegrp == agegrp[case1[i]]] 
   if(length(candi)>1) { 
     slct.id[i,1:(min(length(candi),nc1)+1)] = c(case1[i],sample(candi,size=min(length(candi),nc1))) 
     strata1[i,1:(min(length(candi),nc1)+1)] = rep(i,min(length(candi),nc1)+1) 
     prob.vec[candi] = prob.vec[candi] * (1-min(length(candi),nc1)/length(candi)) 
   } 
   if(length(candi)==1) { 
     slct.id[i,1:2] = c(case1[i],candi) 
     strata1[i,1:2] = rep(i,2) 
     prob.vec[candi] = prob.vec[candi] * (1-min(length(candi),nc1)/length(candi)) 
   } 
 
    
   if(length(candi)==0) { 
     slct.id[i,1] = case1[i] 
     strata1[i,1] = i 






# calculate incl prob as 1- prob.vec 
incl.prob = 1 - prob.vec 
incl.prob[c(slct.id[,1])] = 1 
wt.vec = 1 / incl.prob 
 
study1.id <-  c(c(t(slct.id[,1:(nc1+1)]))) 
study1.id = study1.id[study1.id>0] 
# get rid of duplicates 
study1.id = na.omit(study1.id[!duplicated(study1.id)]) 
 
wt = wt.vec[study1.id] 
 
## Combining variables into datasets for MLE estimation 
 




unslct.data = cbind(pbc2.w[-c(study1.id),c(1:7)], bilir[-c(study1.id)]) 
 
####=====================================#### 





source('Unweight(pbc2).r')     
 
# Full MLE function & significance 
p.ini = c(1.1,1,0.49,-0.11,0.07,0.20,1,1.46,1) 
out.f=optim(par=p.ini, fn=full.mle, unslct.data=unslct.data, cc.data=cc.data, 
  m=20, hessian=T,method="BFGS") 
 
se.full = diag(solve(out.f$hess))^0.5 
t.full = out.f$p / se.full 
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p.full = 2*(1-pnorm(abs(t.full))) 
 
cbind(round(out.f$p,3), round(se.full,3), round(p.full,3)) 
 
# Weighted MLE function 
p.ini = out.f$p 
out.w=optim(par=p.ini, fn=weight.mle, cc.data=cc.data, m=20, hessian=T, 
  method="BFGS") 
 
f1 = unweight.mle(out.w$p, cc.data, 20) 
score = matrix(0,length(f1),length(p.ini))  
for(i in 1:length(p.ini)) { 
  p.prime = out.w$p; p.prime[i]=p.prime[i]+(1e-04*out.w$p[i]) 
  f2 = unweight.mle(p.prime, cc.data, 20) 
  score[,i] = (f2-f1)/(1e-04*out.w$p[i]) 
} 
  
pen.term = matrix(0,length(p.ini),length(p.ini)) 
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for(i in 1:length(f1)) { 
  pen.term = pen.term + (1-cc.data[i,40])/cc.data[i,40]^2 * as.matrix(score[i,])%*%t(as.matrix(score[i,])) 
} 
 
var.hat = (solve(out.w$hess) + solve(out.w$hess)%*%pen.term%*%solve(out.w$hess)) 
 
se.weight = diag(var.hat)^0.5 
t.weight = out.f$p / se.weight 
p.weight = 2*(1-pnorm(abs(t.weight))) 
 











surv.dat1 = cbind(pbc2.w, bilir) 
surv.dat1 = surv.dat1[,c(4:6,2,7,40)] 
surv.dat1 = unlist(surv.dat1) 
surv.dat1 = matrix(surv.dat1, 312, 6) 
 
p.ini = out.w$p[4:8] 
out.surv1 = optim(par=p.ini, fn=surv.bil, surv.dat=surv.dat1, hessian=T, 
 method="BFGS") 
 
se.surv1 = diag(solve(out.surv1$hess))^0.5 
t.surv1 = out.surv1$p / se.surv1 
94 
 
p.surv1 = 2*(1-pnorm(abs(t.surv1))) 
 
cbind(round(out.surv1$p,3), round(se.surv1,3), round(p.surv1,3)) 
 
####====================================#### 
#### Survival analysis (selected cases & controls) #### 
####====================================#### 
 
surv.dat2 = cc.data[,c(4:6,2,7,41)] 
surv.dat2 = unlist(surv.dat2) 
surv.dat2 = matrix(surv.dat2, 209, 6) 
 
p.ini = out.surv1$p 
out.surv2 = optim(par=p.ini, fn=surv.bil, surv.dat=surv.dat2, hessian=T, 
 method="BFGS") 
 
se.surv2 = diag(solve(out.surv2$hess))^0.5 
t.surv2 = out.surv2$p / se.surv2 
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p.surv2 = 2*(1-pnorm(abs(t.surv2))) 
 
cbind(round(out.surv2$p,3), round(se.surv2,3), round(p.surv2,3)) 
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R function of the Full MLE for pbc2 dataset 
####==============================================#### 




#### Using simplest scenario ################################################ 
######## unslct.data: data frame for unselected indiv ########################### 
######## cc.data: data frame for selected indiv ################################ 
######## Vars 4-6: cov assoc with survival #################################### 
######## Vars 2 & 7: years (Ti), status2 (event) ################################ 
######## Vars 8-23 (cc.data): longitudinal measurements (logalc) ################# 
######## Vars 24-39 (cc.data): measurement times ############################ 
######## Var 40 (cc.data): inclusion weight ################################### 
######################################################################## 
 





# m: number of quadrature points 
# p: [1]ln(sigma.b), [2]b1, [3]ln(sigma.eps), [4-6]beta.x, [7]ln(c) 




full.mle = function(p, unslct.data, cc.data, m){ 
 
 quad.weights = gauss.quad.prob(m,dist='normal',mu=p[9], sigma=exp(p[1]))$weights 
 quad.nodes = gauss.quad.prob(m,dist='normal',mu=p[9],sigma=exp(p[1]))$nodes 
 
 long.meas = log(cc.data[,c(8:23)]) 
 time.long = cc.data[,c(24:39)] 
 surv.cov1 = cc.data[, c(4:6)] 
 surv.cov2 = unslct.data[, c(4:6)] 
 event1 = cc.data[,7] 
 event2 = unslct.data[,7] 
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 Ti.1 = cc.data[,2] 
 Ti.2 = unslct.data[,2] 
 quad.sum1 = 0 
 quad.sum2 = 0 
 
 for (k in 1:m){ 
 
      b.rand = quad.nodes[k] 
   
  ## Trajectory component for selected cases and controls 
  traj.dist = matrix(0, 209, 16) 
 
  for (j in 1:16){ 
       
      # normal density for longitudinal measurements 
      traj.dist[,j] = dnorm(long.meas[,j], b.rand + p[2]*time.long[,j], exp(p[3])) 
 
      # replace NA values to be 1 for cumulative product to be calculated 
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      traj.dist[,j] = replace(traj.dist[,j], which(is.na(traj.dist[,j])), 1) 
 
  } 
 
      # Cumulative product of normal density for each indiv 
      traj.comp = traj.dist[,1] * traj.dist[,2] * traj.dist[,3] * 
   traj.dist[,4] * traj.dist[,5] * traj.dist[,6] * traj.dist[,7] * 
    traj.dist[,8] * traj.dist[,9] * traj.dist[,10] * traj.dist[,11] * 
     traj.dist[,12] * traj.dist[,13] * traj.dist[,14] * 
      traj.dist[,15] * traj.dist[,16] 
 
 
      ## Survival component for selected cases and controls 
      # Set up parameters for coefficients for survival covariates 
      beta.x = t(as.matrix(c(p[4:6]))) 
      surv.func = (exp(p[7])/(p[8]*p[2]))*exp(p[8]*b.rand + beta.x%*%t(surv.cov1))* 




      haz.func = (exp(p[7])*exp(p[8]*(b.rand + p[2]*Ti.1) + beta.x%*%t(surv.cov1))) 
      surv.comp = ((haz.func)^event1) * exp(-surv.func) 
 
      ## Evaluate integral at k-th quadrature points and summing up 
      int.like1 = traj.comp * surv.comp * quad.weights[k] 
      quad.sum1 = quad.sum1 + int.like1 
 
      ## Survival component for unselected individuals 
      surv.func = (exp(p[7])/(p[8]*p[2]))*exp(p[8]*b.rand + beta.x%*%t(surv.cov2))* 
        (exp(p[8]*p[2]*Ti.2) - 1) 
 
      haz.func = (exp(p[7])*exp(p[8]*(b.rand + p[2]*Ti.2) + beta.x%*%t(surv.cov2))) 
      surv.comp = ((haz.func)^event2) * exp(-surv.func) 
 
      ## Evaluate integral at k-th quadrature points and summing up 
      int.like2 = surv.comp * quad.weights[k] 




     } 
 
     quad.sum1 = log(quad.sum1) 
     quad.sum2 = log(quad.sum2) 
     logl.mat = c(quad.sum1, quad.sum2) 
     -sum(logl.mat) 
 




R function of the Weighted MLE for pbc2 dataset 
####==================================#### 




#### Only includes selected individuals ######################################## 
######## cc.data: data frame for selected indiv ################################# 
######## Vars 4-6: cov assoc with survival ##################################### 
######## Vars 2 & 7: years (Ti), status2 (event) ################################# 
######## Vars 8-23 (cc.data): longitudinal measurements (logalc) ################## 
######## Vars 24-39 (cc.data): measurement times ############################## 
######## Var 40 (cc.data): inclusion weight #################################### 
######################################################################## 
 





# m: number of quadrature points 
# p: [1]ln(sigma.b1), [2]b1, [3]ln(sigma.eps), [4-6]beta.x, [7]ln(c) 




weight.mle = function(p, cc.data, m){ 
 
 quad.weights = gauss.quad.prob(m,dist='normal',mu=p[9], sigma=exp(p[1]))$weights 
 quad.nodes = gauss.quad.prob(m,dist='normal',mu=p[9],sigma=exp(p[1]))$nodes 
 
 long.meas = log(cc.data[,c(8:23)]) 
 time.long = cc.data[,c(24:39)] 
 surv.cov = cc.data[, c(4:6)] 
 event = cc.data[,7] 
 Ti = cc.data[,2] 
 wt = cc.data[,40] 
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 quad.sum = 0 
 
 for (k in 1:m){ 
 
      b.rand = quad.nodes[k] 
 
  ## Trajectory component for selected cases and controls 
  traj.dist = matrix(0, 209, 16) 
 
  for (j in 1:16){ 
       
      # normal density for longitudinal measurements 
      traj.dist[,j] = dnorm(long.meas[,j], b.rand + p[2]*time.long[,j], exp(p[3])) 
 
      # replace NA values to be 1 for cumulative product to be calculated 
      traj.dist[,j] = replace(traj.dist[,j], which(is.na(traj.dist[,j])), 1) 
 




      # Cumulative product of normal density for each indiv 
      traj.comp = traj.dist[,1] * traj.dist[,2] * traj.dist[,3] * 
   traj.dist[,4] * traj.dist[,5] * traj.dist[,6] * traj.dist[,7] * 
    traj.dist[,8] * traj.dist[,9] * traj.dist[,10] * traj.dist[,11] * 
     traj.dist[,12] * traj.dist[,13] * traj.dist[,14] * 
      traj.dist[,15] * traj.dist[,16] 
 
      ## Survival component for selected cases and controls 
      # Set up parameters for coefficients for survival covariates 
     beta.x = t(as.matrix(c(p[4:6]))) 
      surv.func = (exp(p[7])/(p[8]*p[2]))*exp(p[8]*b.rand + beta.x%*%t(surv.cov))* 
        (exp(p[8]*p[2]*Ti) - 1) 
 
      haz.func = (exp(p[7])*exp(p[8]*(b.rand + p[2]*Ti) + beta.x%*%t(surv.cov))) 
      surv.comp = ((haz.func)^event) * exp(-surv.func) 
 
      ## Evaluate integral at k-th quadrature points and summing up 
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      int.like = traj.comp * surv.comp * quad.weights[k] 
      quad.sum = quad.sum + int.like 
 
     } 
 
     logl.mat = log(quad.sum) * wt 
     -sum(logl.mat) 
 




R function of the unweighted MLE for pbc2 dataset (calculation of sandwich estimator) 
####====================================#### 




#### Only includes selected individuals ######################################## 
######## cc.data: data frame for selected indiv ################################# 
######## Vars 4-6: cov assoc with survival ##################################### 
######## Vars 2 & 7: years (Ti), status2 (event) ################################# 
######## Vars 8-23 (cc.data): longitudinal measurements (logalc) ################## 
######## Vars 24-39 (cc.data): measurement times ############################## 
######## Var 40 (cc.data): inclusion weight ##################################### 
######################################################################## 
 





# m: number of quadrature points 
# p: [1]ln(sigma.b1), [2]b1, [3]ln(sigma.eps), [4-6]beta.x, [7]ln(c) 




unweight.mle = function(p, cc.data, m){ 
 
 quad.weights = gauss.quad.prob(m,dist='normal',mu=p[9], sigma=exp(p[1]))$weights 
 quad.nodes = gauss.quad.prob(m,dist='normal',mu=p[9],sigma=exp(p[1]))$nodes 
 
 long.meas = log(cc.data[,c(8:23)]) 
 time.long = cc.data[,c(24:39)] 
 surv.cov = cc.data[, c(4:6)] 
 event = cc.data[,7] 
 Ti = cc.data[,2] 
 wt = cc.data[,40] 
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 quad.sum = 0 
 
 for (k in 1:m){ 
 
      b.rand = quad.nodes[k] 
 
  ## Trajectory component for selected cases and controls 
  traj.dist = matrix(0, 209, 16) 
 
  for (j in 1:16){ 
       
      # normal density for longitudinal measurements 
      traj.dist[,j] = dnorm(long.meas[,j], b.rand + p[2]*time.long[,j], exp(p[3])) 
 
      # replace NA values to be 1 for cumulative product to be calculated 
      traj.dist[,j] = replace(traj.dist[,j], which(is.na(traj.dist[,j])), 1) 
 




      # Cumulative product of normal density for each indiv 
      traj.comp = traj.dist[,1] * traj.dist[,2] * traj.dist[,3] * 
   traj.dist[,4] * traj.dist[,5] * traj.dist[,6] * traj.dist[,7] * 
    traj.dist[,8] * traj.dist[,9] * traj.dist[,10] * traj.dist[,11] * 
     traj.dist[,12] * traj.dist[,13] * traj.dist[,14] * 
      traj.dist[,15] * traj.dist[,16] 
 
      ## Survival component for selected cases and controls 
      # Set up parameters for coefficients for survival covariates 
     beta.x = t(as.matrix(c(p[4:6]))) 
      surv.func = (exp(p[7])/(p[8]*p[2]))*exp(p[8]*b.rand + beta.x%*%t(surv.cov))* 
        (exp(p[8]*p[2]*Ti) - 1) 
 
      haz.func = (exp(p[7])*exp(p[8]*(b.rand + p[2]*Ti) + beta.x%*%t(surv.cov))) 
      surv.comp = ((haz.func)^event) * exp(-surv.func) 
 
      ## Evaluate integral at k-th quadrature points and summing up 
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      int.like = traj.comp * surv.comp * quad.weights[k] 
      quad.sum = quad.sum + int.like 
 
     } 
 
     logl.mat = log(quad.sum) 
 




R function of the survival analysis for pbc2 dataset 
####======================================================#### 




#### Data frame used: surv.dat ########################################### 
########### 1st 3 vars: cov assoc with survival ############################## 
########### Vars 4-5: years (Ti), status2 (event) ############################# 
########### Var 6: serum bilirubin closest to Ti ############################# 
##################################################################### 
 
#- Likelihood function for optim -# 
#-----------------------------------------# 
 




surv.bil = function(p, surv.dat){ 
 
 surv.cov = surv.dat[,c(1:3)] 
 event = surv.dat[,5] 
 Ti = surv.dat[,4] 
 bil = log(surv.dat[,6]) 
 
 beta.x = t(as.matrix(c(p[1:3]))) 
 delta.Ti = exp(p[4]) * Ti * exp((p[5]*bil) + surv.cov%*%t(beta.x)) 
 haz.func = exp(p[4]) * exp((p[5]*bil) + surv.cov%*%t(beta.x)) 
 surv.comp = ((haz.func)^event) * exp(-delta.Ti) 
 
 logl.mat = log(surv.comp) 
 -sum(logl.mat) 
 




R codes for plotting of individual trajectories for 5 random subjects in PBC dataset 
####=========================#### 
#### Plotting individual trajectories #### 
####=========================#### 
 




## Number of measurements & sample from IDs with at least 10 measurements 
uniq.id = rle(c(pbc2$id)) 
t = uniq.id$length 
 
id.pool = uniq.id$values[which(t>=10)] 
 








pbc.bil = cbind(bilir0, bilir1, bilir2, bilir3, bilir4, bilir5, bilir6, bilir7,  
 bilir8, bilir9, bilir10, bilir11, bilir12, bilir13, bilir14, bilir15) 
 
pbc.samp = pbc.bil[k,] 
 
pbc.samp = log(pbc.samp) 
 
x = c(1:16) 
 
plot(NA,main="Change in Log Serum Bilirubin Levels",ylim=c(-1,3),xlim=c(1,16), 
 xlab="Measurement times",ylab="Log Serum Bilirubin Level") 
axis(1, c(1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16)) 
 
points(x, pbc.samp[1,],type="b",pch=0, lty=2) 
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points(x, pbc.samp[2,],type="b",pch=1, lty=3) 
points(x, pbc.samp[3,],type="b",pch=2) 
points(x, pbc.samp[4,],type="b",pch=3, lty=3) 
points(x, pbc.samp[5,],type="b",pch=4, lty=2) 
  
 
 
 
 
